CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Arctoris›
Library
Arctoris

Arctoris

Arctoris is a British biotechnology company providing automated laboratory research and data-generation services.

HQ
Abingdon, Oxfordshire, GB
Loading
Overview
Compare
Employees
Library

Arctoris - Library

Official pages and third-party coverage in one index.

arctoris.com·29 items across 28 mapped pages · Crawled Sep 29, 2026·

Topics

Publication type

Content origin
Row density

Official pages and third-party coverage in one index

Product

6 pages
  1. Biologics/biologics

    Accelerate Your Biologics Discovery with Arctoris’ Integrated and High-Precision Solutions. Capabilities Overview  Arctoris brings unparalleled expertise and cutting-edge technology to biologics drug discovery. Our comprehensive services span from antibody generation and engineering to functional characterization and optimization. Utilizing our advanced Ulysses® platform, we deliver high-throughput, high-quality data that drives the development of next-generation biologic therapeutics.…

  2. Biophysics/biophysics

    Enrich your Drug Discovery Data with Arctoris’ Precision Biophysics Solutions. Capabilities Overview  Arctoris revolutionizes biophysics in drug discovery by providing unparalleled insights into molecular interactions. Our advanced technologies and expert team empower you to quantitatively evaluate complex interactions, including binary and ternary systems. With high-throughput capabilities and AI/ML-ready data, we elucidate binding mechanisms and kinetics…

  3. Cell Biology/cell-biology

    Unlock the Complexities of Cellular Mechanisms with Arctoris’ Advanced Cell Biology Solutions. Capabilities Overview  Arctoris brings cell biology to the forefront of drug discovery by offering comprehensive solutions that bridge molecular targets and physiological relevance. Our state-of-the-art platforms and expert team enable you to validate target engagement and assess functional activity within complex cellular systems,…

  4. Protein Science/protein-science

    Empower Your Drug Discovery with Arctoris’ Exceptional Protein Science Expertise. Capabilities Overview  At Arctoris, we understand that high-quality proteins are foundational to successful drug discovery. Our expert team specializes in the production, purification, and characterization of proteins, providing you with critical reagents for biochemical, biophysical, and structural studies. Utilizing advanced technologies and automation, we deliver…

Blog

6 pages
  1. Building the Future of Drug Discovery/building-the-future-of-drug-discovery

    Foundation Models and the Power of Proprietary Experimental Data In recent years, foundation models have revolutionised fields from natural language processing to image generation. Now, these powerful AI systems are transforming drug discovery. By learning generalisable patterns across chemical and biological data, foundation models are unlocking new opportunities to identify novel small molecules and biologics,…

  2. Frontier of Drug Discovery/frontier-of-drug-discovery

    Arctoris is featured as a series partner in the Biology for a Better Tomorrow digital series, an initiative created with the Royal Society of Biology to highlight how biological sciences are addressing global challenges and advancing innovation across healthcare, sustainability, and environmental protection. The series brings together researchers, academic institutions, and biotechnology companies to showcase…

  3. High Throughput Transcriptomics for Scalable Phenotypic Screening Alithea Genomics Collaboration/high-throughput-transcriptomics-for-scalable-phenotypic-screening-alithea-genomics-collaboration

    Scalable drug discovery demands phenotypic data that is both mechanistically rich and compatible with high-throughput, AI/ML-driven analysis, yet conventional RNA-seq workflows remain difficult to scale…

  4. Macrocycles the Next Chapter in Small Molecule Drug Discovery/macrocycles-the-next-chapter-in-small-molecule-drug-discovery

    The Therapeutic Potential of Macrocycles in Drug Discovery Structural and Conformational Properties: Macrocycles exhibit distinct physicochemical characteristics that differentiate them from conventional small molecules. Their cyclic architectures confer a degree of conformational rigidity while maintaining three-dimensional complexity. This combination enables well-defined interactions with biological targets. As a result, macrocycles often demonstrate high binding affinity and…

Press

6 pages
  1. Arctoris Automated Platform Accelerates Drug Discovery/arctoris-automated-platform-accelerates-drug-discovery

    Oxford-headquartered Arctoris progresses programmes from target to hit, lead, and candidate with superior efficiency, accuracy, and confidence. Key to the company’s capabilities is the unique combination of robotics and data science, enabling better data to be generated faster and better decisions made earlier.  Drug discovery is a series of decisions – which Target to focus on, which hit to progress,…

  2. Arctoris Featured in Drug Discovery World Accelerating Covid 19 Research with the Ulysses Platform/arctoris-featured-in-drug-discovery-world-accelerating-covid-19-research-with-the-ulysses-platform

    Arctoris was featured in a Drug Discovery World (DDW) webinar discussing how automated experimentation platforms can accelerate drug discovery, particularly during urgent global health challenges such as the COVID-19 pandemic. The presentation highlights how automated laboratory workflows can enable scientists to rapidly generate high-quality experimental data while maintaining reproducibility and scalability. By integrating robotics, automated…

  3. Arctoris Featured in Fierce Biotech Building a New Executive Leadership Team/arctoris-featured-in-fierce-biotech-building-a-new-executive-leadership-team

    Arctoris was featured in Fierce Biotech following a period of significant growth, highlighting the company’s expansion and the development of a strengthened executive leadership team. The article reports that Arctoris co-founder Tom Fleming, Ph.D., has taken on the role of CEO, succeeding co-founder Martin-Immanuel Bittner, M.D., Ph.D., who led the company from 2018 to early…

  4. Arctoris Featured in Labiotech Collaboration with Molecule to Advance Lab Automation/arctoris-featured-in-labiotech-collaboration-with-molecule-to-advance-lab-automation

    Arctoris was featured in Labiotech, in an article highlighting a collaboration between the Oxford-based automation company and Swiss software firm Molecule. The partnership aims to improve drug discovery by combining laboratory automation with digital tools designed to simplify the sharing and development of drug intellectual property. The collaboration addresses a key challenge facing the pharmaceutical…

Careers & Hiring

6 pages
  1. Careers/careers

    Let’s Grow Together Arctoris is transforming drug discovery and we’re scaling fast  – and we’re just getting started.​​ If you’re ambitious, curious, and ready to make an impact, join us on this incredible growth journey. explore open roles Make a Difference. Be Part of Something Big. Join Arctoris, where scientific rigour, automation and data shapes…

  2. Florence Eustache/career-testimonial/florence-eustache

    At Arctoris, we’ve replaced manual bottlenecks with a high-speed, automated engine for drug discovery. We are truly doing now what the industry will embrace as the standard in the future. In addition to this exciting, innovative environment, Arctoris is a space that is as inclusive and friendly as it is scientifically rigorous. If your motivation…

  3. Positions/positions

    Full time at Milton Park, full-time, Milton Park (HQ, UK)

  4. Sally Cullen/career-testimonial/sally-cullen

    Chief People Officer There’s a energy at Arctoris that’s genuinely hard to describe until you’ve felt it. We’re a team of scientists and problem-solvers who are deeply passionate about what we do.  The team don’t just accept a challenge, they go looking for one! That shared drive creates something special: a workplace that’s fast-moving, intellectually…

About

1 page
  1. About Us/about-us

    Arctoris was founded to solve a fundamental problem in drug discovery: biology has not kept pace with the scale, rigor, and data quality modern science demands.

Contact

1 page
  1. Contact Us/contact-us

    Contact Us

Homepage

1 page
  1. Homepage/

    We accelerate the discovery of new medicines by combining the power of robotics, data science, and deep biological expertise to generate precise, reproducible, and AI-ready data.

Terms & Conditions

1 page
  1. Policies/policies

    Policies Date of last update: 2023-12-15 INTRODUCTION Arctoris Limited (“Arctoris”, “we” or “us”) respects your privacy and is committed to protecting your personal data. This privacy policy describes how Arctoris collects and uses personal data collected when you access our platforms and websites, including arctoris.com, when you otherwise access our experimental, analytical and computational services…

Not yet classified

1 page
  1. arctoris.com/

    We accelerate the discovery of new medicines by combining the power of robotics, data science, and deep biological expertise to generate precise, reproducible, and AI-ready data.